LGALS3BP was markedly elevated in COVID-19 patients as discovered by DIA-MS and confirmed by ELISA, but unchanged between control and sepsis patients without COVID-19 (Fig. 7d). This evidence concerns the gene LGALS3BP and COVID-19.